![man wearing black t-shirt close-up photography](https://thebrios.com/wp-content/uploads/2024/05/bioxcel-therapeutics-inc-investors-investigation-300x200.jpg)
BioXcel Therapeutics, Inc. (BTAI)
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Investigation
03/30/2022
Initial Lawsuit
04/14/2022
Lawsuit Progression
06/13/2022
Investors investigation into Stronghold’s initial public offering (IPO) statement about miners demand, pre-sold supply of mining equipment in the industry, difficulties to obtain miners and expand mining capacity.
03/29/2022
Stronghold announces its financial results for the fiscal year 2021. Regarding the delivery of the 15,000 MV7 ASIC SHA256 miners, Stronghold disclosed it had “only received approximately 3,300 of the total 15,000 miners ordered from MinerVa, despite an initial delivery deadline of December 31, 2021.”
“This delivery deadline was later revised to April 30, 2022 based on communications with MinerVa. Stronghold continues to have active dialogue with MinerVa regarding its delivery schedule and operational capabilities, but the Company does not have sufficient information from MinerVa to provide an update or a timeline on future deliveries, or if the Company can expect any future deliveries.“
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$6.97 | $10.25 | $-3.28 | -32% |
This is a class action on behalf of persons and entities that purchased or otherwise acquired Stronghold Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the company’s October 2021 initial public offering (IPO).
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors:
(1) that contracted suppliers, including MinerVa, were reasonably likely to miss anticipated delivery quantities and deadlines;
(2) that, due to strong demand and pre-sold supply of mining equipment in the industry, Stronghold would experience difficulties obtaining miners outside of confirmed purchase orders;
(3) that, as a result of the foregoing, there was a significant risk that Stronghold could not expand its mining capacity as expected;
(4) that, as a result, Stronghold would likely experience significant losses; and
(5) that, as a result of the foregoing, defendants’ positive statements about the company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
The lead plaintiff deadline has passed, we will update this page as the lawsuit progresses.
Last event retrieved on 09/25/2022.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.